lation for incompetent great saphenous veins
(VeClose). J Vasc Surg 2015;61:985-94.
86. Morrison N, Gibson K, Vasquez M, Weiss R, Cher D, Madsen M, et al.
VeClose trial 12-month outcomes of cyanoacrylate closure versus
radiofrequency ablation for incompetent great saphenous veins.
J Vasc Surg 2017;5:321-30.
87. Morrison N, Kolluri R, Vasquez M, Madsen M, Jones A, Gibson K.
Comparison of cyanoacrylate closure and radiofrequency ablation
for the treatment of incompetent great saphenous veins: 36-month
outcomes of the VeClose randomized controlled trial. Phlebology
2019;34:380-90.
88. Morrison N, Gibson K, Vasquez M, Weiss R, Jones A. Five-year
extension study of patients from a randomized clinical trial
(VeClose) comparing cyanoacrylate closure versus radiofrequency
ablation for the treatment of incompetent great saphenous veins.
J Vasc Surg Venous Lymphat Disord 2020;8:978-89.
89. Rai A, Porsalman M, Khatony A, Sobhiyeh M. Comparison of foam
sclerotherapy versus radiofrequency ablation in the treatment of

90.

91.

92.

93.
94.

95.

96.

97.

98.

99.

100.

101.

102.

103.

104.

105.

106.

107.

108.

primary varicose veins due to incompetent great saphenous vein:
randomized clinical trial. J Vasc Nurs 2019;37:226-31.
TawÔ¨Åk AM, Sorour WA, El-Laboudy ME. Laser ablation versus
mechanochemical ablation in the treatment of primary varicose
veins: a randomized clinical trial. J Vasc Surg Venous Lymphat
Disord 2020;8:211-